期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

髓鞘修复与多发性硬化 被引量：2

The role of myelin repair in multiple sclerosis
原文传递
导出
摘要 多发性硬化(MS)是以中枢神经系统炎性脱髓鞘为特征的自身免疫性疾病,神经功能障碍与髓鞘和轴索损伤有关。MS 动物模型研究认为:髓鞘修复是治疗 MS 极有前景的途径。中枢神经系统存在少突胶质细胞前体细胞(OPCs),在髓鞘修复和再生过程起关键作用。由于 MS 病人 OPC 分化受抑制,因此,在髓鞘再生过程中调控 OPCs 分化是髓鞘修复的重点。另外,移植外源性的髓鞘形成细胞促进髓鞘修复和神经再生,是修复 MS 脱髓鞘和轴索损伤的重要途径。 Multiple sclerosis （MS） is an autoimmune disease of the central nervous system characterized by inflammation and demyelination. The neurological disability is associated with myelin and axon damage. Researches on animal model of MS indicated that remyelination appears to be one of the most feasible restoration strategies. The adult CNS contains oligodendrocyte precursor cells （OPC） that play a key role in myelin repair and remyelination. The differentiation of OPCs in MS is inhibited so that regulation of OPC differentiation during remyelination is critical to myelin repair. Besides, one possibility to achieve remyelination and subsequent restoration of neuronal function is to provide an exogenous source of myelinating cells via transplantation. This review focuses on concepts that are important for developing strategies of remyelination.
作者 曾彦英 顾冰洁
机构地区 南京医科大学免疫与微生物学教研室
出处 《国际免疫学杂志》 CAS 2007年第6期439-443,共5页 International Journal of Immunology
基金 江苏省卫生厅科学基金项目(H200504)
关键词 多发性硬化 髓鞘修复 少突胶质细胞前体细胞 Multiple sclerosis Myelin repair Oligodendrocyte precursor cell （OPC）
分类号 R744.5~1 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献25

  • 1Zhao C, Fancy SP, Kotter MR, et al. Mechanisms of CNS remyelination-the key to therapeutic advances. J Neurol Sci, 2005,233 ( 1-2 ) :1 87-91.
  • 2Chen Y, Balasubramaniyan V, Peng J, et al. Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat Protoc, 2007,2 (5) : 1044-1051.
  • 3Chen Y, Tian D, Ku L, Osterhout DJ,et al. The selective RNA-binding protein quaking Ⅰ(QKI) is necessary and sufficient for promoting. oligodendroglia differentiation. J Biol Chem, 2007,282 ( 32 ) : 23553- 23560.
  • 4Wolswijk G. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain ,2002, 125 (2) : 338-349.
  • 5Wilson HC, Scolding NJ, Raine CS. Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions. J Neuroimmunol, 2006,176 ( 1-2 ) : 162-173.
  • 6Sim FJ, Zhao C, Penderis J, Franklin RJM. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J Neurosci, 2002,22 ( 7 ) : 2451-2459.
  • 7Woodruff RH, Fruttiger M, Richardson WD, et al. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol Cell Neurosci, 2004,25(2) :252-262.
  • 8Cid C, Alvarez-Cermeno JC, Camafeita E, et al. Antibodies reactive to heat shock protein 90 induce oligodendrocyte precursor cell death in culture. Implications for demyelination in multiple sclerosis. FASEB J,2004,18(2) :409-411.
  • 9Tsai HH, Tessier-Lavigne M, Miller RH. Netrin 1 mediates spinal cord oligodendrocyte precursor dispersal. Development, 2003, 130 (10) :2095-2105.
  • 10Zhang H, Vutskits L, Calaora V, et al. A role for the polysialic acid-neural cell adhesion molecule in PDGF-induced chemotaxis of oligodendrocyte precursor cells. J Cell Sci ,2004,117 ( Pt 1 ) :93-103.

同被引文献20

  • 1Zhang Y, Zhang J, Navrazhina K, et al. TGFbetal induces Jagged1 expression in astrocytes via ALK5 and Smad3 and regulates the balance between oligodendrocyte progenitor proliferation and differentiation[J]. Glia, 2010, 58(8) : 964- 974.
  • 2Zhang Y, Argaw AT, Gurfein BT, et al. Notch1 signaling plays a role in regulating precursor differentiation during CNS[J]. Proc Natl Acad Sci, 2009, 106(45): 19162-19167.
  • 3Seifert T, Bauer J, Weissert R, et al. Notchl and its ligand Jagged1 are,present in remyelination in a T-cell- and antibody-mediated model of inflammatory demyelination[J]. Acta Neuropathol, 2007, 113(2) :195-203.
  • 4John GR, Shankar SL, Shafit-Zagardo B, et al. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation[J]. Nat Med, 2002, 8 (10): 1115-1121.
  • 5Tripathi RB, Rivers LE, Young KM, et al. NG2 glia generate new oligodendroeytes hut few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease[J]. J Neurosci, S010, 30 (48): 16383- 16389.
  • 6Chari DM. Remyelination in multiple sclerosis[J]. Int Rev Neurobiol, 2007, 79(1) :589-620.
  • 7Aharoni R, Herschkovitz A, Eilam R, et al. Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis [J ]. Proc Natl Aead Sci, 2008, 105(32):11358-11363.
  • 8Seifert T, Bauer J, Weissert R, et al. Notch1 and its ligand Jaggedl are present in remyelination in a T-cell- and antibody-mediated model of inflammatory demyelination[J]. Acta Neuropathol, 2007, 113(2) : 195-203.
  • 9Jurynczyk failure to M, Jurewicz A, Bielecki B, et al. Overcoming repair demyelination in EAE: gamma-secretase inhibition of Notch signaling[J]. J Neurol Sci, 2008, 265 (2) :5-11.
  • 10Aharoni R, Herschkovitz A, Eilam R, et al. Demyelina- tion arrest and remyelination induced by glatirarner acetatetreatment of experimental autoimmune encephatomyelitis[J]. Proc Natl Acad Sci USA,2008,105(32):11358-11363.

引证文献2

二级引证文献1

国际免疫学杂志
2007年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部